Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mini Rev Med Chem ; 23(21): 2073-2088, 2023.
Article in English | MEDLINE | ID: mdl-36843374

ABSTRACT

Malaria is a public health problem that causes thousands of deaths, primarily in children in African regions. Artemisinin-based combination therapies (ACTs) have helped to save thousands of lives; however, due to Plasmodium's resistance to available treatments, there is a need to search for new low-cost drugs that act through different mechanisms of action to contain this disease. This review shows that compounds with sulfonamide moiety, possibly, act as inhibitors of P. falciparum carbonic anhydrases, moreover, when linked to a variety of heterocycles potentiate the activities of these compounds and may be used in the design of new antimalarial drugs.

2.
Mini Rev Med Chem ; 23(4): 497-512, 2023.
Article in English | MEDLINE | ID: mdl-35430972

ABSTRACT

Leprosy is a Neglected Tropical Disease (NTDs) caused by Mycobacterium leprae (M. leprae). The treatment is considered effective, however, the high dose Multidrug Therapy (MDT) for a long period and its adverse effects result in the abandonment of the treatment by patients. Indeed, antimicrobial resistance is still an obstacle that must be overcome in the treatment of leprosy. In the present article, we reviewed the WHO guidelines for the chemotherapy of leprosy and the methods of synthesis of these drugs.


Subject(s)
Leprostatic Agents , Leprosy , Humans , Drug Therapy, Combination , Leprostatic Agents/pharmacology , Leprostatic Agents/therapeutic use , Leprosy/etiology , Leprosy/microbiology , Mycobacterium leprae , Guidelines as Topic
SELECTION OF CITATIONS
SEARCH DETAIL
...